Abel Hall LLC
RLAY icon

Abel Hall LLC’s Relay Therapeutics RLAY Stock Holding History

Abel Hall LLC’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$332K Buy
18,380
+18
+0.1% +$345 0.06% 399
2026
Q2 		$344K Buy
18,362
+125
+0.7% +$1.82K 0.06% 408
2026
Q1 		$181K Buy
18,237
+5,253
+40% +$47K 0.04% 635
2025
Q4 		$110K Buy
12,984
+1,809
+16% +$12.9K 0.03% 605
2025
Q3 		$58.3K Buy
+11,175
New +$42.6K 0.02% 296

Other funds holding RLAY

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Valeo Financial Advisors
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.14% 1-Year Est. Return
Yorktown Management & Research Company
Yorktown Management & Research Company Forest, Virginia $150M AUM 39.02% 1-Year Est. Return
LF
Lighthouse Financial Largo, Florida $222M AUM 23.63% 1-Year Est. Return
Great Lakes Retirement
Great Lakes Retirement Sandusky, Ohio $1.14B AUM 34.02% 1-Year Est. Return

Abel Hall LLC's RLAY Position: Q3 2026 in Review

Abel Hall LLC increased its Relay Therapeutics (RLAY) stake by 0.1% in Q3 2026, buying an estimated $345 and bringing the position to 18,380 shares worth $332K. The position accounts for 0.06% of the portfolio, ranked #399.

Abel Hall LLC first reported a position in RLAY in Q3 2025 and has held it in 5 quarters since. The position peaked at $344K in Q2 2026. 32 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • Abel Hall LLC held 18,380 shares of Relay Therapeutics worth $332K as of Q3 2026.
  • Abel Hall LLC bought 18 Relay Therapeutics shares in Q3 2026, an estimated $345.
  • Relay Therapeutics made up 0.06% of Abel Hall LLC's portfolio in Q3 2026, its #399 holding.
  • Abel Hall LLC first reported a position in Relay Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Abel Hall LLC's Relay Therapeutics position peaked at $344K in Q2 2026.
  • 32 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.